-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Lj1GVsTeHjJwRH+lreDIl/MiPRr4twniQ7U3Z6XxZzPCG+8aoONc3ZnhRLbNmhzJ +9PPdzzRuIgEjrttp/y+Fw== 0001144204-07-006095.txt : 20070330 0001144204-07-006095.hdr.sgml : 20070330 20070209112929 ACCESSION NUMBER: 0001144204-07-006095 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070209 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OXIS INTERNATIONAL INC CENTRAL INDEX KEY: 0000109657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 941620407 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 323 VINTAGE PARK DRIVE, SUITE B CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6502122568 MAIL ADDRESS: STREET 1: 323 VINTAGE PARK DRIVE, SUITE B CITY: FOSTER CITY STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/ DATE OF NAME CHANGE: 19850312 CORRESP 1 filename1.htm
RICHARDSON & PATEL LLP
10900 Wilshire Boulevard, Suite 500
Los Angeles, California 90024-6525
Telephone (310) 208-1182
Telecopier (310) 208-1154

February 9, 2007

Filed as Correspondence Via EDGAR

Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549-6010
Attn: Mary K. Fraser, Esq.
 
Re:
OXIS International, Inc.
Form SB-2 Registration Statement filed December 8, 2006
(File No. 333-139216)
 
Dear Ms. Fraser:

On behalf of OXIS International, Inc. (the “Company”), I write in reference to the above registration statement filed on December 8, 2006, in addition to the comments received from the staff (“Staff”) of the Securities and Exchange Commission in a letter dated December 19, 2006, and our response letter and Amendment No. 1 filed on January 10, 2007, and our response letter and Amendment No. 2 filed on January 23, 2007, amending the above referenced registration statement. References in this letter to “we,” “our,” or “us” mean the Company or its advisors, as the context may require.

In a series of telephone conversations from January 12, 2007 through February 8, 2007, the Staff requested that we revise the executive compensation data in the registration statement to comply with the recent changes to rules regarding executive compensation and related person disclosure for small business issuers. In response to this request, the Company has further amended its registration statement to include a revised summary compensation table, the outstanding equity awards at fiscal year-end table, and the director compensation table. These revisions appear on pages 65, 66, 67 and 68 of Amendment No. 3 to the registration statement filed today (February 9, 2007).

If you have any questions, please contact me by telephone at (310) 208-1182, or by facsimile at (310) 208-1154.
 
 
Very truly yours,

/s/ Edgar D. Park, Esq.
 
cc:
Marvin S. Hausman, MD
OXIS International, Inc.
 
 
 
 
 -----END PRIVACY-ENHANCED MESSAGE-----